Figure 3.

TOX3 and LOC643714 mRNA expression was lowest in tumours of the basal subtype. The mRNA expression levels in: A) TOX3 (p < 0.001) and B) LOC643714 (p < 0.001) in five breast tumour subtypes. ANOVA was used to test for differences in expression between the different subtypes. The difference in TOX3 expression between basal and ERBB2 tumours was significant (p = 0.02).